文献速递神经肌肉病

1999-2022年美国肌无力相关死亡率的人群与地理趋势

Demographic and Geographic Trends in Myasthenia Gravis-Related Mortality in the United States, 1999-2022.
PubMed 文献 · Neurology · 2025-03-28

该回顾性人群研究基于美国CDC WONDER死亡记录,以ICD编码G70.0识别肌无力(MG),分析1999-2022年MG相关死亡的人群与地理趋势。研究期间共37,075例MG相关死亡,年龄调整死亡率从6.21/百万升至9.51/百万,年均变化+2.42%,各年龄组、性别、地区及种族和族裔均见上升。

要点

  • MG相关年龄调整死亡率从1999年6.21/百万升至2022年9.51/百万,年均变化+2.42%。
  • 65岁及以上人群年龄调整死亡率由28.23升至47.36,升高82.35%。
  • 男性年龄调整死亡率升高66.3%,女性升高29.6%。

核心结论

  • 1999-2022年美国MG相关死亡率上升,以高龄和男性人群最为突出,值得探究其潜在原因。

研究设计与样本

  • 回顾性人群研究,使用美国CDC WONDER死亡记录,以ICD编码G70.0识别MG,并按性别、年龄组(25-64岁及>64岁)、种族和族裔及地理区域分层,采用Joinpoint回归分析年龄调整死亡率趋势,并以MG作为根本死因进行敏感性分析。

主要发现

  • 研究期间共37,075例MG相关死亡,其中89.6%为64岁以上人群,44.7%为女性。
  • MG相关年龄调整死亡率从6.21(95% CI 5.58-6.58)/百万升至9.51(95% CI 9.14-9.88)/百万,平均年度变化百分比为+2.42(95% CI 1.98-2.87)。
  • 无论年龄组、性别、地区或种族和族裔,均观察到MG相关死亡率上升。
  • 研究期间男性MG相关年龄调整死亡率升高66.3%,女性升高29.6%。
  • 65岁及以上人群MG相关年龄调整死亡率由28.23升至47.36,升高82.35%。

局限性

  • 原文述局限性包括依赖ICD编码。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The prevalence and incidence of myasthenia gravis (MG) have been increasing, globally and in the United States. The literature lacks data on MG-related mortality (MGRM) and its trends in the United States. We aimed to examine nationwide demographic and geographic trends of MGRM from 1999 to 2022. METHODS: This retrospective population-based study used data regarding MG-related deaths (MGRD) from Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research mortality records. The International Classification of Diseases (ICD) code, G70.0, was used to identify MG. We stratified deaths by sex, age groups (25-64 years and older than 64 years), race and ethnicity, and geographical location. Joinpoint regression was performed to examine trends in age-adjusted mortality rates (AAMRs). Sensitivity analysis was performed using MG as an underlying cause of death (UCD). RESULTS: During the study period, there were 37,075 MGRD (89.6% were older than 64 years, and 44.7% were female individuals). From 1999 to 2022, the MG-related AAMR increased significantly from 6.21 (95% CI 5.58-6.58) per 1 million population to 9.51 (95% CI 9.14-9.88) per 1 million population, with an average annual percent change of +2.42 (95% CI 1.98-2.87). The increase in MGRM was observed regardless of age group, sex, region, or race and ethnicity. The MG-related AAMR increased by 66.3% in male individuals and 29.6% in female individuals over the study period. For individuals aged 65 years or older, there was a concerning increase in MG-related AAMR by 82.35% from 28.23 to 47.36. There was a peak in MGRM during the coronavirus disease 2019 pandemic (2020-2022), and sensitivity analysis revealed that the trend in MGRM remained consistent as both UCD and contributing cause of death. DISCUSSION: The rising MGRM over the 23-year period is concerning and warrants investigation into the underlying causes for this trend. This increase was most prominent in older and male individuals. The growing burden of MG in the United States and globally might pose a serious challenge to health care in the future. Limitations of this study include reliance on ICD codes. Future work needs to take these trends and disparities into consideration and focus on improving MGRM.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Al-Salahat A, Abdul Jabbar AB, Sharma R, et al. Demographic and Geographic Trends in Myasthenia Gravis-Related Mortality in the United States, 1999-2022. Neurology. 2025. PMID: 40153683. doi:10.1212/WNL.0000000000213505

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。